These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 2824596

  • 1. Detection and characterization of autoantibodies blocking the TSH-dependent cAMP production using FRTL-5 cells.
    Chiovato L, Vitti P, Lombardi A, Lopez G, Santini F, Macchia E, Fenzi GF, Mammoli C, Battiato S, Pinchera A.
    J Endocrinol Invest; 1987 Aug; 10(4):383-8. PubMed ID: 2824596
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of thyrotropin-stimulated adenylate cyclase activation and growth of rat thyroid cells, FRTL-5, by immunoglobulin G from patients with primary myxedema: comparison with activities of thyrotropin-binding inhibitor immunoglobulins.
    Cho BY, Shong YK, Lee HK, Koh CS, Min HK.
    Acta Endocrinol (Copenh); 1989 Jan; 120(1):99-106. PubMed ID: 2563181
    [Abstract] [Full Text] [Related]

  • 3. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
    Dallas JS, Cunningham SJ, Patibandla SA, Seetharamaiah GS, Morris JC, Tahara K, Kohn LD, Prabhakar BS.
    Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759
    [Abstract] [Full Text] [Related]

  • 4. Role of blocking TSH receptor antibodies on the development of hypothyroidism and thyroid atrophy in primary myxedema.
    Cho BY, Shong YK, Lee HK, Koh CS, Min HK, Sohn I.
    Korean J Intern Med; 1989 Jul; 4(2):108-17. PubMed ID: 2577255
    [Abstract] [Full Text] [Related]

  • 5. Blocking anti-thyrotropin receptor antibodies desensitize cultured human thyroid cells.
    Madec AM, Clavel S, Stefanutti A, Orgiazzi J.
    Endocrinology; 1988 Oct; 123(4):2062-6. PubMed ID: 3416826
    [Abstract] [Full Text] [Related]

  • 6. Relationship between potency of blocking type thyrotropin-binding inhibitor immunoglobulin in three women with primary myxedema and thyroid function of their neonates.
    Inomata H, Sasaki N, Tamaru K, Ushiku H, Niimi H, Nakajima H.
    Endocrinol Jpn; 1986 Jun; 33(3):353-9. PubMed ID: 3019652
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Negative correlation between the conversion of thyrotropin receptor-bound blocking type thyrotropin receptor antibody to the stimulating type by anti-human IgG antibodies and the biological activity of blocking type thyrotropin receptor antibody.
    Cho BY, Shong MH, Chung JH, Lee HK, Koh CS, Min HK.
    J Korean Med Sci; 1993 Oct; 8(5):355-60. PubMed ID: 7905742
    [Abstract] [Full Text] [Related]

  • 9. Graves' IgG stimulation of iodide uptake in FRTL-5 rat thyroid cells: a clinical assay complementing FRTL-5 assays measuring adenylate cyclase and growth-stimulating antibodies in autoimmune thyroid disease.
    Marcocci C, Valente WA, Pinchera A, Aloj SM, Kohn LD, Grollman EF.
    J Endocrinol Invest; 1983 Dec; 6(6):463-71. PubMed ID: 6689493
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of thyrotropin-induced growth of rat thyroid cells, FRTL-5, by immunoglobulin G from patients with primary myxedema.
    Iida Y, Konishi J, Kasagi K, Misaki T, Arai K, Tokuda Y, Torizuka K.
    J Clin Endocrinol Metab; 1987 Jan; 64(1):124-30. PubMed ID: 3023425
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Maternal thyroid-blocking immunoglobulins in congenital hypothyroidism.
    Brown RS, Keating P, Mitchell E.
    J Clin Endocrinol Metab; 1990 May; 70(5):1341-6. PubMed ID: 2335576
    [Abstract] [Full Text] [Related]

  • 17. Thyrotrophin receptor blocking antibodies: incidence, characterization and in-vitro synthesis.
    Kraiem Z, Lahat N, Glaser B, Baron E, Sadeh O, Sheinfeld M.
    Clin Endocrinol (Oxf); 1987 Oct; 27(4):409-21. PubMed ID: 2830061
    [Abstract] [Full Text] [Related]

  • 18. The IgG subclass distribution of TSH receptor blocking antibodies in primary hypothyroidism.
    Kraiem Z, Cho BY, Sadeh O, Shong MH, Pickerill P, Weetman AP.
    Clin Endocrinol (Oxf); 1992 Aug; 37(2):135-40. PubMed ID: 1395064
    [Abstract] [Full Text] [Related]

  • 19. Sera of patients with idiopathic myxedema contain IgG which block TSH-stimulated thyroid adenylate cyclase.
    Vitti P, Chiovato L, Lombardi A, Lopez G, Mammoli C, Santini F, Fenzi GF, Pinchera A.
    Acta Endocrinol Suppl (Copenh); 1987 Aug; 281():348-51. PubMed ID: 3475916
    [No Abstract] [Full Text] [Related]

  • 20. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K, Yamazaki K, Yamada E, Kanaji Y, Miura M, Obara T.
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.